| 0 |
CSF HIV VIRUS IDENTIFIED |
14 |
0.6087 |
| 1 |
PERINATAL HBV INFECTION |
9 |
0.5294 |
| 2 |
CSF VIRUS IDENTIFIED |
30 |
0.4286 |
| 3 |
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA |
50 |
0.3876 |
| 4 |
HBV-DNA POLYMERASE INCREASED |
5 |
0.3846 |
| 5 |
ULTRASOUND ANTENATAL SCREEN |
34 |
0.3542 |
| 6 |
RETROPERITONEAL DISORDER |
8 |
0.3478 |
| 7 |
CONGENITAL TUBERCULOSIS |
4 |
0.3333 |
| 8 |
ANAL CHLAMYDIA INFECTION |
4 |
0.3333 |
| 9 |
HYDRANENCEPHALY |
7 |
0.2917 |
| 10 |
HIV VIRAEMIA |
61 |
0.2905 |
| 11 |
PERITONEAL THICKENING |
8 |
0.2857 |
| 12 |
HYDROMYELIA |
7 |
0.2500 |
| 13 |
HIV PERIPHERAL NEUROPATHY |
4 |
0.2353 |
| 14 |
VIRAL MUTATION IDENTIFIED |
707 |
0.1918 |
| 15 |
ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC |
7 |
0.1892 |
| 16 |
VIROLOGIC FAILURE |
744 |
0.1382 |
| 17 |
HIV ASSOCIATED NEPHROPATHY |
7 |
0.1373 |
| 18 |
RENAL TUBULAR DYSFUNCTION |
71 |
0.1257 |
| 19 |
HEPATITIS B E ANTIGEN POSITIVE |
5 |
0.1190 |
| 20 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS |
39 |
0.1164 |
| 21 |
CSF HIV ESCAPE SYNDROME |
16 |
0.1159 |
| 22 |
BIRTH MARK |
24 |
0.1154 |
| 23 |
ACTH STIMULATION TEST ABNORMAL |
4 |
0.1143 |
| 24 |
PERITONEAL CYST |
6 |
0.1111 |
| 25 |
HEPATITIS D |
9 |
0.1071 |
| 26 |
SCROTAL CYST |
9 |
0.1059 |
| 27 |
AIDS ENCEPHALOPATHY |
6 |
0.1034 |
| 28 |
CONGENITAL KNEE DISLOCATION |
4 |
0.1000 |
| 29 |
HEREDITARY OPTIC ATROPHY |
7 |
0.1000 |
| 30 |
CHRONIC HEPATITIS B |
31 |
0.0978 |
| 31 |
CONGENITAL UMBILICAL HERNIA |
34 |
0.0912 |
| 32 |
HYPOPHOSPHATAEMIC OSTEOMALACIA |
23 |
0.0871 |
| 33 |
FANCONI SYNDROME ACQUIRED |
152 |
0.0865 |
| 34 |
HYPERANDROGENISM |
8 |
0.0851 |
| 35 |
PATHOGEN RESISTANCE |
749 |
0.0821 |
| 36 |
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION |
22 |
0.0791 |
| 37 |
HEPATITIS B DNA INCREASED |
53 |
0.0786 |
| 38 |
BLOOD HIV RNA |
4 |
0.0769 |
| 39 |
GENOTYPE DRUG RESISTANCE TEST POSITIVE |
78 |
0.0759 |
| 40 |
HEMIVERTEBRA |
12 |
0.0710 |
| 41 |
SECONDARY SYPHILIS |
7 |
0.0707 |
| 42 |
HEPATITIS B DNA ASSAY POSITIVE |
9 |
0.0703 |
| 43 |
GENETIC POLYMORPHISM |
4 |
0.0702 |
| 44 |
BLOOD HIV RNA INCREASED |
121 |
0.0667 |
| 45 |
FANCONI SYNDROME |
94 |
0.0664 |
| 46 |
MITOCHONDRIAL TOXICITY |
54 |
0.0658 |
| 47 |
THYMUS ENLARGEMENT |
10 |
0.0625 |
| 48 |
AIDS RELATED COMPLICATION |
4 |
0.0615 |
| 49 |
MEDIASTINAL SHIFT |
4 |
0.0597 |
| 50 |
CONGENITAL TERATOMA |
5 |
0.0581 |
| 51 |
CONGENITAL KNEE DEFORMITY |
4 |
0.0556 |
| 52 |
HIV-ASSOCIATED NEUROCOGNITIVE DISORDER |
6 |
0.0541 |
| 53 |
DEXTROCARDIA |
10 |
0.0535 |
| 54 |
ECTOPIC KIDNEY |
5 |
0.0526 |
| 55 |
TRISOMY 18 |
20 |
0.0525 |
| 56 |
BRACHYDACTYLY |
10 |
0.0508 |
| 57 |
HYDROPS FOETALIS |
31 |
0.0506 |
| 58 |
LIPODYSTROPHY ACQUIRED |
105 |
0.0494 |
| 59 |
ENLARGED CLITORIS |
8 |
0.0485 |
| 60 |
CEREBROVASCULAR ARTERIOVENOUS MALFORMATION |
4 |
0.0460 |
| 61 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
221 |
0.0443 |
| 62 |
IMMUNE RECONSTITUTION SYNDROME |
55 |
0.0426 |
| 63 |
CONGENITAL NAEVUS |
6 |
0.0423 |
| 64 |
GENE MUTATION IDENTIFICATION TEST POSITIVE |
17 |
0.0404 |
| 65 |
RENAL ANEURYSM |
9 |
0.0375 |
| 66 |
HIV TEST POSITIVE |
24 |
0.0363 |
| 67 |
MACROCEPHALY |
14 |
0.0361 |
| 68 |
MENINGOMYELOCELE |
21 |
0.0350 |
| 69 |
HEPATITIS B |
201 |
0.0333 |
| 70 |
GLYCOSURIA |
45 |
0.0333 |
| 71 |
ACUTE HIV INFECTION |
8 |
0.0324 |
| 72 |
MENINGOCELE |
5 |
0.0318 |
| 73 |
ANTI-THYROID ANTIBODY INCREASED |
4 |
0.0317 |
| 74 |
RICKETS |
6 |
0.0317 |
| 75 |
EXTRAOCULAR MUSCLE PARESIS |
14 |
0.0305 |
| 76 |
HETEROTAXIA |
5 |
0.0299 |
| 77 |
RENAL TUBULAR DISORDER |
84 |
0.0298 |
| 78 |
ADRENOGENITAL SYNDROME |
4 |
0.0296 |
| 79 |
CONGENITAL HYDROCEPHALUS |
15 |
0.0296 |
| 80 |
CONGENITAL SKIN DIMPLES |
7 |
0.0290 |
| 81 |
SPINE MALFORMATION |
10 |
0.0288 |
| 82 |
OSTEOMALACIA |
44 |
0.0285 |
| 83 |
HEPATITIS B REACTIVATION |
88 |
0.0277 |
| 84 |
COLLATERAL CIRCULATION |
4 |
0.0276 |
| 85 |
LEFT VENTRICULAR ENLARGEMENT |
7 |
0.0275 |
| 86 |
EXTRAPULMONARY TUBERCULOSIS |
8 |
0.0271 |
| 87 |
ACUTE HEPATITIS B |
9 |
0.0271 |
| 88 |
ACQUIRED GENE MUTATION |
35 |
0.0267 |
| 89 |
PORTAL HYPERTENSIVE GASTROPATHY |
15 |
0.0266 |
| 90 |
BONE METABOLISM DISORDER |
8 |
0.0266 |
| 91 |
NEUROSYPHILIS |
4 |
0.0263 |
| 92 |
ANION GAP ABNORMAL |
7 |
0.0261 |
| 93 |
ACQUIRED IMMUNODEFICIENCY SYNDROME |
13 |
0.0250 |
| 94 |
ANKYLOGLOSSIA CONGENITAL |
10 |
0.0249 |
| 95 |
PORTAL VENOUS GAS |
9 |
0.0248 |
| 96 |
LARYNGOMALACIA |
8 |
0.0239 |
| 97 |
NON-ALCOHOLIC FATTY LIVER |
8 |
0.0237 |
| 98 |
MESENTERIC ARTERY THROMBOSIS |
9 |
0.0234 |
| 99 |
PORPHYRIA NON-ACUTE |
10 |
0.0230 |
| 100 |
RENAL HYPOPLASIA |
5 |
0.0229 |
| 101 |
VIRAL LOAD INCREASED |
89 |
0.0229 |
| 102 |
MICROGNATHIA |
11 |
0.0220 |
| 103 |
CD4 LYMPHOCYTES DECREASED |
47 |
0.0219 |
| 104 |
HEPATITIS B SURFACE ANTIGEN POSITIVE |
6 |
0.0219 |
| 105 |
CLEFT LIP AND PALATE |
24 |
0.0215 |
| 106 |
TRISOMY 21 |
27 |
0.0214 |
| 107 |
NON-CIRRHOTIC PORTAL HYPERTENSION |
8 |
0.0213 |
| 108 |
GASTRIC VARICES |
10 |
0.0212 |
| 109 |
CENTRAL NERVOUS SYSTEM INFLAMMATION |
7 |
0.0211 |
| 110 |
NEURAL TUBE DEFECT |
15 |
0.0206 |
| 111 |
CUSHING'S SYNDROME |
14 |
0.0201 |
| 112 |
PLACENTAL INSUFFICIENCY |
16 |
0.0199 |
| 113 |
DRUG RESISTANCE |
501 |
0.0195 |
| 114 |
LOW SET EARS |
8 |
0.0195 |
| 115 |
RENAL TUBULAR ACIDOSIS |
42 |
0.0192 |
| 116 |
STILLBIRTH |
91 |
0.0188 |
| 117 |
SKULL MALFORMATION |
12 |
0.0187 |
| 118 |
NEPHROPATHY TOXIC |
206 |
0.0183 |
| 119 |
MALARIA |
12 |
0.0170 |
| 120 |
ARNOLD-CHIARI MALFORMATION |
16 |
0.0168 |
| 121 |
RETINAL TOXICITY |
17 |
0.0165 |
| 122 |
INFECTIVE ANEURYSM |
8 |
0.0162 |
| 123 |
OESOPHAGEAL ATRESIA |
10 |
0.0160 |
| 124 |
HYDROCELE |
17 |
0.0159 |
| 125 |
MITOCHONDRIAL CYTOPATHY |
7 |
0.0159 |
| 126 |
BONE TUBERCULOSIS |
6 |
0.0157 |
| 127 |
MULTIPLE-DRUG RESISTANCE |
48 |
0.0155 |
| 128 |
PSYCHIATRIC DECOMPENSATION |
30 |
0.0153 |
| 129 |
NASOPHARYNGEAL CANCER |
4 |
0.0153 |
| 130 |
BENIGN HYDATIDIFORM MOLE |
5 |
0.0151 |
| 131 |
DISEASE RISK FACTOR |
6 |
0.0149 |
| 132 |
NECROTISING ENTEROCOLITIS NEONATAL |
6 |
0.0148 |
| 133 |
OPHTHALMOPLEGIA |
23 |
0.0146 |
| 134 |
BLOOD CORTICOTROPHIN DECREASED |
7 |
0.0143 |
| 135 |
HYPERSPLENISM |
7 |
0.0141 |
| 136 |
HIV INFECTION |
42 |
0.0139 |
| 137 |
CSF TEST ABNORMAL |
7 |
0.0139 |
| 138 |
HEPATIC ARTERY THROMBOSIS |
4 |
0.0137 |
| 139 |
ADRENAL SUPPRESSION |
11 |
0.0130 |
| 140 |
POLYDACTYLY |
15 |
0.0129 |
| 141 |
CYTOMEGALOVIRUS CHORIORETINITIS |
25 |
0.0128 |
| 142 |
BLOOD PHOSPHORUS ABNORMAL |
6 |
0.0127 |
| 143 |
CHRONIC HEPATITIS C |
5 |
0.0127 |
| 144 |
ANOMALY OF EXTERNAL EAR CONGENITAL |
4 |
0.0127 |
| 145 |
VANISHING BILE DUCT SYNDROME |
14 |
0.0126 |
| 146 |
HYPERPHOSPHATAEMIA |
27 |
0.0125 |
| 147 |
MENINGITIS TUBERCULOUS |
7 |
0.0125 |
| 148 |
ABDOMINAL SEPSIS |
11 |
0.0125 |
| 149 |
LUNG TRANSPLANT REJECTION |
8 |
0.0121 |
| 150 |
HYPERBILIRUBINAEMIA NEONATAL |
7 |
0.0120 |
| 151 |
PLAGIOCEPHALY |
6 |
0.0120 |
| 152 |
PROTRUSION TONGUE |
7 |
0.0120 |
| 153 |
MICROALBUMINURIA |
9 |
0.0119 |
| 154 |
BLOOD TRIGLYCERIDES DECREASED |
4 |
0.0119 |
| 155 |
HEPATITIS C RNA INCREASED |
4 |
0.0117 |
| 156 |
PLACENTAL DISORDER |
11 |
0.0116 |
| 157 |
VIRAEMIA |
16 |
0.0115 |
| 158 |
LIPOHYPERTROPHY |
7 |
0.0113 |
| 159 |
ANAL ATRESIA |
6 |
0.0112 |
| 160 |
HYPOPHOSPHATAEMIA |
83 |
0.0112 |
| 161 |
EXOMPHALOS |
6 |
0.0112 |
| 162 |
SEPSIS NEONATAL |
9 |
0.0111 |
| 163 |
PSYCHOMOTOR SKILLS IMPAIRED |
29 |
0.0111 |
| 164 |
SYPHILIS |
8 |
0.0110 |
| 165 |
LIVER TRANSPLANT |
40 |
0.0110 |
| 166 |
NECROTISING RETINITIS |
7 |
0.0109 |
| 167 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
12 |
0.0109 |
| 168 |
NODULAR REGENERATIVE HYPERPLASIA |
7 |
0.0109 |
| 169 |
VARICES OESOPHAGEAL |
33 |
0.0109 |
| 170 |
CHOLESTASIS OF PREGNANCY |
5 |
0.0109 |
| 171 |
MENINGITIS CRYPTOCOCCAL |
18 |
0.0103 |
| 172 |
JOINT HYPEREXTENSION |
4 |
0.0103 |
| 173 |
GENE MUTATION |
20 |
0.0101 |
| 174 |
PORTAL HYPERTENSION |
31 |
0.0100 |
| 175 |
KAPOSI'S SARCOMA |
5 |
0.0100 |
| 176 |
PANCREATITIS RELAPSING |
8 |
0.0098 |
| 177 |
VISCERAL LEISHMANIASIS |
7 |
0.0097 |
| 178 |
DIAPHRAGMATIC HERNIA |
6 |
0.0097 |
| 179 |
SPINA BIFIDA |
20 |
0.0096 |
| 180 |
GLOMERULOSCLEROSIS |
6 |
0.0095 |
| 181 |
LIPOATROPHY |
9 |
0.0095 |
| 182 |
VOLVULUS |
22 |
0.0093 |
| 183 |
FOETAL GROWTH RESTRICTION |
56 |
0.0092 |
| 184 |
HEPATOCELLULAR CARCINOMA |
69 |
0.0091 |
| 185 |
FOETAL EXPOSURE DURING PREGNANCY |
727 |
0.0089 |
| 186 |
PULMONARY TUBERCULOSIS |
38 |
0.0089 |
| 187 |
PROTEIN URINE |
8 |
0.0088 |
| 188 |
MENTAL DISABILITY |
5 |
0.0087 |
| 189 |
GRAVITATIONAL OEDEMA |
6 |
0.0086 |
| 190 |
PLEOCYTOSIS |
5 |
0.0086 |
| 191 |
CEREBRAL TOXOPLASMOSIS |
8 |
0.0086 |
| 192 |
BLOOD PHOSPHORUS DECREASED |
31 |
0.0085 |
| 193 |
CRYSTAL NEPHROPATHY |
5 |
0.0084 |
| 194 |
DEVELOPMENTAL HIP DYSPLASIA |
7 |
0.0084 |
| 195 |
DEPRESSION SUICIDAL |
29 |
0.0084 |
| 196 |
BLOOD URIC ACID DECREASED |
4 |
0.0082 |
| 197 |
DEPRESSIVE SYMPTOM |
29 |
0.0082 |
| 198 |
VENTRICULAR SEPTAL DEFECT |
47 |
0.0082 |
| 199 |
DRUG LEVEL CHANGED |
5 |
0.0079 |
| 200 |
LYMPHOCYTIC INFILTRATION |
8 |
0.0079 |
| 201 |
CONGENITAL ANOMALY |
61 |
0.0079 |
| 202 |
OSTEOPOROTIC FRACTURE |
15 |
0.0078 |
| 203 |
BLOOD ALBUMIN ABNORMAL |
4 |
0.0077 |
| 204 |
C-REACTIVE PROTEIN DECREASED |
5 |
0.0077 |
| 205 |
PULMONARY HYPOPLASIA |
6 |
0.0076 |
| 206 |
FOETAL HEART RATE ABNORMAL |
7 |
0.0076 |
| 207 |
LIVE BIRTH |
63 |
0.0075 |
| 208 |
CONGENITAL NOSE MALFORMATION |
4 |
0.0075 |
| 209 |
FOETAL EXPOSURE DURING DELIVERY |
5 |
0.0074 |
| 210 |
OESOPHAGEAL VARICES HAEMORRHAGE |
16 |
0.0074 |
| 211 |
METABOLIC SYNDROME |
12 |
0.0073 |
| 212 |
LOW BIRTH WEIGHT BABY |
58 |
0.0073 |
| 213 |
TEARFULNESS |
31 |
0.0072 |
| 214 |
DEATH NEONATAL |
10 |
0.0072 |
| 215 |
TWIN PREGNANCY |
6 |
0.0071 |
| 216 |
CRYPTORCHISM |
8 |
0.0071 |
| 217 |
SJS-TEN OVERLAP |
5 |
0.0071 |
| 218 |
ANENCEPHALY |
4 |
0.0071 |
| 219 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
25 |
0.0071 |
| 220 |
HEPATIC FIBROSIS |
24 |
0.0070 |
| 221 |
CARDIAC VENTRICULAR THROMBOSIS |
9 |
0.0070 |
| 222 |
OSTEOCHONDROSIS |
8 |
0.0069 |
| 223 |
ABORTION SPONTANEOUS |
268 |
0.0067 |
| 224 |
DISSEMINATED TUBERCULOSIS |
17 |
0.0066 |
| 225 |
HUMAN HERPESVIRUS 8 INFECTION |
4 |
0.0066 |
| 226 |
OESOPHAGEAL CANDIDIASIS |
26 |
0.0065 |
| 227 |
PORTAL VEIN THROMBOSIS |
21 |
0.0065 |
| 228 |
DYSLIPIDAEMIA |
33 |
0.0065 |
| 229 |
BLOOD BILIRUBIN DECREASED |
4 |
0.0065 |
| 230 |
ATYPICAL MYCOBACTERIAL INFECTION |
9 |
0.0064 |
| 231 |
NECROTISING COLITIS |
8 |
0.0063 |
| 232 |
HYPERCHLORAEMIA |
4 |
0.0063 |
| 233 |
PREMATURE RUPTURE OF MEMBRANES |
15 |
0.0062 |
| 234 |
RENAL INFARCT |
9 |
0.0062 |
| 235 |
NEPHROGENIC DIABETES INSIPIDUS |
7 |
0.0061 |
| 236 |
PSYCHOMOTOR RETARDATION |
17 |
0.0060 |
| 237 |
SYNDACTYLY |
5 |
0.0060 |
| 238 |
CAESAREAN SECTION |
69 |
0.0059 |
| 239 |
OSTEOPOROSIS |
243 |
0.0059 |
| 240 |
ENCEPHALITIS VIRAL |
7 |
0.0057 |
| 241 |
EYELID PTOSIS |
58 |
0.0057 |
| 242 |
HILAR LYMPHADENOPATHY |
5 |
0.0057 |
| 243 |
INTERMITTENT CLAUDICATION |
9 |
0.0057 |
| 244 |
FOETAL DISTRESS SYNDROME |
12 |
0.0057 |
| 245 |
RENAL ATROPHY |
7 |
0.0056 |
| 246 |
CONGENITAL HYDRONEPHROSIS |
4 |
0.0056 |
| 247 |
PREMATURE DELIVERY |
89 |
0.0056 |
| 248 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
15 |
0.0056 |
| 249 |
LIPIDS ABNORMAL |
4 |
0.0055 |
| 250 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
12 |
0.0054 |
| 251 |
PREMATURE BABY |
160 |
0.0053 |
| 252 |
RENAL TUBULAR NECROSIS |
52 |
0.0053 |
| 253 |
ANAEMIA MACROCYTIC |
11 |
0.0051 |
| 254 |
OLIGOHYDRAMNIOS |
17 |
0.0051 |
| 255 |
HEPATOSPLENOMEGALY |
13 |
0.0051 |
| 256 |
PYURIA |
5 |
0.0051 |
| 257 |
SMALL FOR DATES BABY |
25 |
0.0050 |
| 258 |
HIGH DENSITY LIPOPROTEIN INCREASED |
5 |
0.0050 |
| 259 |
PREMATURE LABOUR |
28 |
0.0049 |
| 260 |
NEUROLOGICAL SYMPTOM |
28 |
0.0049 |
| 261 |
DYSBIOSIS |
4 |
0.0049 |
| 262 |
RENAL COLIC |
11 |
0.0049 |
| 263 |
ATRIAL SEPTAL DEFECT |
40 |
0.0048 |
| 264 |
GENERALISED ANXIETY DISORDER |
7 |
0.0048 |
| 265 |
WHITE MATTER LESION |
6 |
0.0047 |
| 266 |
PNEUMONIA PNEUMOCOCCAL |
7 |
0.0047 |
| 267 |
MATERNAL DRUGS AFFECTING FOETUS |
36 |
0.0047 |
| 268 |
HEPATIC CIRRHOSIS |
86 |
0.0046 |
| 269 |
MATERNAL EXPOSURE DURING PREGNANCY |
393 |
0.0044 |
| 270 |
INFECTION REACTIVATION |
5 |
0.0044 |
| 271 |
PROTEINURIA |
83 |
0.0044 |
| 272 |
CEREBRAL VENTRICLE DILATATION |
5 |
0.0043 |
| 273 |
DYSMORPHISM |
10 |
0.0042 |
| 274 |
ECTOPIC PREGNANCY |
13 |
0.0042 |
| 275 |
HEPATORENAL SYNDROME |
7 |
0.0041 |
| 276 |
RENAL TUBULAR INJURY |
5 |
0.0041 |
| 277 |
EPIDERMAL NECROSIS |
4 |
0.0041 |
| 278 |
GLOMERULONEPHRITIS |
10 |
0.0041 |
| 279 |
ABORTION INDUCED |
38 |
0.0040 |
| 280 |
GLOMERULAR FILTRATION RATE DECREASED |
49 |
0.0040 |
| 281 |
ABORTION MISSED |
5 |
0.0039 |
| 282 |
EXPOSURE DURING PREGNANCY |
243 |
0.0039 |
| 283 |
FIBROSIS |
12 |
0.0039 |
| 284 |
HYPOSPADIAS |
8 |
0.0038 |
| 285 |
OBLITERATIVE BRONCHIOLITIS |
5 |
0.0038 |
| 286 |
REBOUND EFFECT |
43 |
0.0038 |
| 287 |
TREATMENT NONCOMPLIANCE |
208 |
0.0038 |
| 288 |
HYPERBILIRUBINAEMIA |
39 |
0.0038 |
| 289 |
HYPERTENSIVE NEPHROPATHY |
4 |
0.0037 |
| 290 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
6 |
0.0037 |
| 291 |
PATHOLOGICAL FRACTURE |
19 |
0.0037 |
| 292 |
HEPATITIS FULMINANT |
11 |
0.0037 |
| 293 |
BLOOD BICARBONATE DECREASED |
7 |
0.0037 |
| 294 |
CACHEXIA |
19 |
0.0037 |
| 295 |
HEPATIC CYTOLYSIS |
47 |
0.0037 |
| 296 |
OPTIC ATROPHY |
6 |
0.0037 |
| 297 |
CRYPTOCOCCOSIS |
6 |
0.0037 |
| 298 |
FOETAL DEATH |
19 |
0.0037 |
| 299 |
LYMPHADENOPATHY MEDIASTINAL |
7 |
0.0037 |
| 300 |
DRUG LEVEL BELOW THERAPEUTIC |
20 |
0.0036 |
| 301 |
TREATMENT FAILURE |
300 |
0.0036 |
| 302 |
MYELITIS TRANSVERSE |
5 |
0.0035 |
| 303 |
CHRONIC GASTRITIS |
8 |
0.0035 |
| 304 |
TALIPES |
11 |
0.0035 |
| 305 |
KIDNEY FIBROSIS |
6 |
0.0035 |
| 306 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
5 |
0.0035 |
| 307 |
HEPATITIS TOXIC |
9 |
0.0035 |
| 308 |
LUNG OPACITY |
9 |
0.0034 |
| 309 |
HISTOPLASMOSIS |
6 |
0.0034 |
| 310 |
COCCIDIOIDOMYCOSIS |
4 |
0.0034 |
| 311 |
DRUG-INDUCED LIVER INJURY |
105 |
0.0033 |
| 312 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
4 |
0.0033 |
| 313 |
EXPOSURE VIA BREAST MILK |
13 |
0.0033 |
| 314 |
VITRITIS |
6 |
0.0032 |
| 315 |
APLASIA PURE RED CELL |
11 |
0.0032 |
| 316 |
OSTEOSCLEROSIS |
5 |
0.0032 |
| 317 |
NEPHRITIS INTERSTITIAL |
4 |
0.0032 |
| 318 |
GLUCOSE URINE PRESENT |
4 |
0.0031 |
| 319 |
CUSHINGOID |
10 |
0.0031 |
| 320 |
HEART DISEASE CONGENITAL |
11 |
0.0031 |
| 321 |
CYTOMEGALOVIRUS COLITIS |
7 |
0.0030 |
| 322 |
AUTOIMMUNE HEPATITIS |
21 |
0.0030 |
| 323 |
HEPATIC FAILURE |
90 |
0.0030 |
| 324 |
MYCOBACTERIAL INFECTION |
5 |
0.0029 |
| 325 |
HEPATITIS C |
35 |
0.0029 |
| 326 |
BLOOD LACTIC ACID INCREASED |
15 |
0.0028 |
| 327 |
PROTEIN URINE PRESENT |
14 |
0.0028 |
| 328 |
HYPERPARATHYROIDISM SECONDARY |
7 |
0.0028 |
| 329 |
OSTEOPENIA |
42 |
0.0028 |
| 330 |
CEREBELLAR SYNDROME |
6 |
0.0027 |
| 331 |
BILIARY DILATATION |
4 |
0.0027 |
| 332 |
RENAL IMPAIRMENT |
227 |
0.0027 |
| 333 |
HEPATIC NECROSIS |
10 |
0.0027 |
| 334 |
MARASMUS |
4 |
0.0026 |
| 335 |
LICHENOID KERATOSIS |
6 |
0.0026 |
| 336 |
HEPATIC MASS |
5 |
0.0026 |
| 337 |
ATROPHY |
5 |
0.0026 |
| 338 |
NASAL SEPTUM DEVIATION |
5 |
0.0026 |
| 339 |
OCULAR ICTERUS |
11 |
0.0025 |
| 340 |
INHIBITORY DRUG INTERACTION |
4 |
0.0025 |
| 341 |
LIMB DEFORMITY |
4 |
0.0025 |
| 342 |
RENAL TRANSPLANT |
9 |
0.0025 |
| 343 |
BLOOD CREATININE INCREASED |
160 |
0.0024 |
| 344 |
ALANINE AMINOTRANSFERASE INCREASED |
149 |
0.0024 |
| 345 |
ILLUSION |
4 |
0.0024 |
| 346 |
IGA NEPHROPATHY |
4 |
0.0024 |
| 347 |
HISTIOCYTOSIS HAEMATOPHAGIC |
7 |
0.0024 |
| 348 |
FOOD AVERSION |
4 |
0.0024 |
| 349 |
GAZE PALSY |
4 |
0.0023 |
| 350 |
HEPATIC CANCER |
56 |
0.0023 |
| 351 |
ENCEPHALITIS |
16 |
0.0023 |
| 352 |
DIPLOPIA |
60 |
0.0023 |
| 353 |
PROCEDURAL HAEMORRHAGE |
9 |
0.0023 |
| 354 |
PREGNANCY ON ORAL CONTRACEPTIVE |
6 |
0.0023 |
| 355 |
INTRA-ABDOMINAL FLUID COLLECTION |
4 |
0.0022 |
| 356 |
BLOOD PHOSPHORUS INCREASED |
6 |
0.0022 |
| 357 |
PREGNANCY |
44 |
0.0022 |
| 358 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
18 |
0.0022 |
| 359 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
9 |
0.0022 |
| 360 |
BLOOD CHOLESTEROL DECREASED |
4 |
0.0021 |
| 361 |
HEPATIC NEOPLASM |
7 |
0.0021 |
| 362 |
DRUG INTERACTION |
339 |
0.0021 |
| 363 |
SPLENOMEGALY |
25 |
0.0021 |
| 364 |
NASAL OBSTRUCTION |
4 |
0.0021 |
| 365 |
TRANSPLANT REJECTION |
17 |
0.0021 |
| 366 |
CONTRAINDICATED PRODUCT ADMINISTERED |
64 |
0.0021 |
| 367 |
DIABETES INSIPIDUS |
5 |
0.0021 |
| 368 |
RENAL FAILURE ACUTE |
88 |
0.0021 |
| 369 |
HYPERTRIGLYCERIDAEMIA |
12 |
0.0020 |
| 370 |
STRABISMUS |
6 |
0.0020 |
| 371 |
HEPATIC ENCEPHALOPATHY |
19 |
0.0020 |
| 372 |
ASPARTATE AMINOTRANSFERASE INCREASED |
108 |
0.0020 |
| 373 |
BRAIN HERNIATION |
6 |
0.0020 |
| 374 |
HYPERPHAGIA |
8 |
0.0020 |
| 375 |
CAROTID ARTERY STENOSIS |
7 |
0.0020 |
| 376 |
LIPIDS INCREASED |
4 |
0.0020 |
| 377 |
FACIAL PARESIS |
7 |
0.0020 |
| 378 |
SKIN HYPERPIGMENTATION |
17 |
0.0020 |
| 379 |
POLYURIA |
16 |
0.0020 |
| 380 |
VITAMIN D DEFICIENCY |
19 |
0.0019 |
| 381 |
HYPERPARATHYROIDISM |
4 |
0.0019 |
| 382 |
UMBILICAL HERNIA |
9 |
0.0019 |
| 383 |
LUNG ABSCESS |
4 |
0.0019 |
| 384 |
ALANINE AMINOTRANSFERASE ABNORMAL |
4 |
0.0019 |
| 385 |
GESTATIONAL DIABETES |
9 |
0.0019 |
| 386 |
AREFLEXIA |
5 |
0.0019 |
| 387 |
EXOPHTHALMOS |
4 |
0.0019 |
| 388 |
TOOTH INJURY |
8 |
0.0018 |
| 389 |
BACTERIAL SEPSIS |
6 |
0.0018 |
| 390 |
NORMAL NEWBORN |
10 |
0.0018 |
| 391 |
DIABETIC NEPHROPATHY |
4 |
0.0018 |
| 392 |
HEPATITIS |
46 |
0.0018 |
| 393 |
NECROSIS |
10 |
0.0018 |
| 394 |
HEPATOTOXICITY |
40 |
0.0018 |
| 395 |
OSTEONECROSIS |
59 |
0.0018 |
| 396 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
18 |
0.0018 |
| 397 |
CHOLANGITIS |
11 |
0.0018 |
| 398 |
LACTIC ACIDOSIS |
57 |
0.0018 |
| 399 |
CREATININE RENAL CLEARANCE DECREASED |
7 |
0.0017 |
| 400 |
PARANOIA |
30 |
0.0017 |
| 401 |
HYPOVOLAEMIA |
10 |
0.0017 |
| 402 |
BONE EROSION |
6 |
0.0017 |
| 403 |
CREPITATIONS |
5 |
0.0017 |
| 404 |
HAEMOLYTIC ANAEMIA |
15 |
0.0017 |
| 405 |
ORAL CANDIDIASIS |
22 |
0.0017 |
| 406 |
CHRONIC KIDNEY DISEASE |
126 |
0.0017 |
| 407 |
INTESTINAL ISCHAEMIA |
9 |
0.0016 |
| 408 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
47 |
0.0016 |
| 409 |
PARADOXICAL DRUG REACTION |
6 |
0.0016 |
| 410 |
BLOOD BILIRUBIN INCREASED |
44 |
0.0016 |
| 411 |
METABOLIC ACIDOSIS |
52 |
0.0016 |
| 412 |
ACUTE HEPATIC FAILURE |
22 |
0.0016 |
| 413 |
NEPHROPATHY |
15 |
0.0016 |
| 414 |
DERMATITIS EXFOLIATIVE |
8 |
0.0016 |
| 415 |
BLOOD CREATINE INCREASED |
7 |
0.0016 |
| 416 |
SKIN LESION |
43 |
0.0016 |
| 417 |
MENINGITIS ASEPTIC |
7 |
0.0016 |
| 418 |
LOW DENSITY LIPOPROTEIN INCREASED |
12 |
0.0015 |
| 419 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0015 |
| 420 |
HYPERSENSITIVITY VASCULITIS |
4 |
0.0015 |
| 421 |
BLOOD ALBUMIN DECREASED |
12 |
0.0015 |
| 422 |
EXPOSURE DURING BREAST FEEDING |
5 |
0.0015 |
| 423 |
LIVER INJURY |
37 |
0.0015 |
| 424 |
CYTOLYTIC HEPATITIS |
5 |
0.0015 |
| 425 |
ALCOHOL POISONING |
4 |
0.0015 |
| 426 |
HYPERLACTACIDAEMIA |
4 |
0.0015 |
| 427 |
BK VIRUS INFECTION |
5 |
0.0015 |
| 428 |
DRUG LEVEL DECREASED |
15 |
0.0015 |
| 429 |
B-CELL LYMPHOMA |
5 |
0.0015 |
| 430 |
LUNG INFILTRATION |
13 |
0.0015 |
| 431 |
HYDROCEPHALUS |
8 |
0.0015 |
| 432 |
PSYCHOTIC DISORDER |
43 |
0.0015 |
| 433 |
ACIDOSIS |
11 |
0.0014 |
| 434 |
GASTROENTERITIS |
21 |
0.0014 |
| 435 |
INTRACRANIAL PRESSURE INCREASED |
8 |
0.0014 |
| 436 |
FRACTURE |
27 |
0.0014 |
| 437 |
SLEEP TERROR |
6 |
0.0014 |
| 438 |
HEPATOMEGALY |
14 |
0.0014 |
| 439 |
SKIN PLAQUE |
12 |
0.0014 |
| 440 |
STAPHYLOCOCCAL SEPSIS |
7 |
0.0014 |
| 441 |
JAUNDICE |
38 |
0.0014 |
| 442 |
RASH MACULO-PAPULAR |
31 |
0.0014 |
| 443 |
HEPATIC LESION |
6 |
0.0014 |
| 444 |
TUBULOINTERSTITIAL NEPHRITIS |
26 |
0.0014 |
| 445 |
BONE LESION |
5 |
0.0014 |
| 446 |
SOCIAL AVOIDANT BEHAVIOUR |
8 |
0.0014 |
| 447 |
RALES |
8 |
0.0014 |
| 448 |
CYTOMEGALOVIRUS VIRAEMIA |
6 |
0.0013 |
| 449 |
HEPATIC FUNCTION ABNORMAL |
50 |
0.0013 |
| 450 |
HYDRONEPHROSIS |
10 |
0.0013 |
| 451 |
ASCITES |
39 |
0.0013 |
| 452 |
DRUG EXPOSURE DURING PREGNANCY |
45 |
0.0013 |
| 453 |
CHEMOTHERAPY |
5 |
0.0013 |
| 454 |
EYE MOVEMENT DISORDER |
9 |
0.0013 |
| 455 |
MASTICATION DISORDER |
4 |
0.0013 |
| 456 |
PREGNANCY WITH IMPLANT CONTRACEPTIVE |
6 |
0.0013 |
| 457 |
PAPULE |
9 |
0.0013 |
| 458 |
BRAIN OEDEMA |
16 |
0.0013 |
| 459 |
POLYDIPSIA |
5 |
0.0013 |
| 460 |
END STAGE RENAL DISEASE |
23 |
0.0013 |
| 461 |
BILE DUCT STONE |
4 |
0.0013 |
| 462 |
IMMUNOSUPPRESSION |
11 |
0.0012 |
| 463 |
BLOOD TRIGLYCERIDES INCREASED |
22 |
0.0012 |
| 464 |
ADRENAL INSUFFICIENCY |
15 |
0.0012 |
| 465 |
DRUG INTOLERANCE |
119 |
0.0012 |
| 466 |
PERIPHERAL VENOUS DISEASE |
5 |
0.0012 |
| 467 |
HERPES VIRUS INFECTION |
7 |
0.0012 |
| 468 |
LYMPHADENOPATHY |
42 |
0.0012 |
| 469 |
HEPATIC PAIN |
5 |
0.0012 |
| 470 |
ALCOHOLISM |
5 |
0.0012 |
| 471 |
MALNUTRITION |
13 |
0.0012 |
| 472 |
HAEMATOTOXICITY |
11 |
0.0012 |
| 473 |
ACUTE KIDNEY INJURY |
177 |
0.0012 |
| 474 |
SKIN NECROSIS |
6 |
0.0012 |
| 475 |
GRANULOMA |
4 |
0.0012 |
| 476 |
LIVER DISORDER |
51 |
0.0011 |
| 477 |
AORTIC STENOSIS |
4 |
0.0011 |
| 478 |
DRUG LEVEL INCREASED |
19 |
0.0011 |
| 479 |
BLOOD UREA INCREASED |
19 |
0.0011 |
| 480 |
NYSTAGMUS |
6 |
0.0011 |
| 481 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
28 |
0.0011 |
| 482 |
HEPATIC STEATOSIS |
21 |
0.0011 |
| 483 |
STEVENS-JOHNSON SYNDROME |
25 |
0.0011 |
| 484 |
HAEMORRHAGIC DIATHESIS |
4 |
0.0011 |
| 485 |
STRESS FRACTURE |
6 |
0.0011 |
| 486 |
LIVER FUNCTION TEST ABNORMAL |
32 |
0.0011 |
| 487 |
LYMPHOMA |
17 |
0.0011 |
| 488 |
CUTANEOUS VASCULITIS |
4 |
0.0011 |
| 489 |
NEUROTOXICITY |
19 |
0.0011 |
| 490 |
TRANSAMINASES INCREASED |
24 |
0.0011 |
| 491 |
RENAL INJURY |
32 |
0.0011 |
| 492 |
BRADYPHRENIA |
7 |
0.0011 |
| 493 |
ARTERIOSCLEROSIS |
10 |
0.0011 |
| 494 |
RHABDOMYOLYSIS |
44 |
0.0011 |
| 495 |
SPINAL FRACTURE |
21 |
0.0010 |
| 496 |
SUBCUTANEOUS ABSCESS |
5 |
0.0010 |
| 497 |
MYOPATHY |
9 |
0.0010 |
| 498 |
NEPHROTIC SYNDROME |
7 |
0.0010 |
| 499 |
MASS |
14 |
0.0010 |
| 500 |
AZOTAEMIA |
4 |
0.0010 |
| 501 |
TYPE 1 DIABETES MELLITUS |
6 |
0.0010 |
| 502 |
FOOT DEFORMITY |
11 |
0.0010 |
| 503 |
DUODENAL ULCER |
7 |
0.0010 |
| 504 |
MYASTHENIA GRAVIS |
8 |
0.0010 |
| 505 |
PNEUMONIA BACTERIAL |
9 |
0.0010 |
| 506 |
TYPE 2 DIABETES MELLITUS |
33 |
0.0010 |
| 507 |
LIVER FUNCTION TEST INCREASED |
21 |
0.0010 |
| 508 |
ARTHRITIS BACTERIAL |
4 |
0.0010 |
| 509 |
STATUS EPILEPTICUS |
11 |
0.0010 |
| 510 |
HYPERURICAEMIA |
4 |
0.0010 |
| 511 |
VISUAL FIELD DEFECT |
7 |
0.0010 |
| 512 |
ANAEMIA |
184 |
0.0010 |
| 513 |
BONE DENSITY DECREASED |
30 |
0.0010 |
| 514 |
TACHYPNOEA |
13 |
0.0010 |
| 515 |
CENTRAL NERVOUS SYSTEM LESION |
13 |
0.0009 |
| 516 |
RENAL FAILURE |
124 |
0.0009 |
| 517 |
PSEUDOMONAS INFECTION |
8 |
0.0009 |
| 518 |
HYPERCHOLESTEROLAEMIA |
9 |
0.0009 |
| 519 |
DIABETES MELLITUS |
71 |
0.0009 |
| 520 |
CHROMATURIA |
21 |
0.0009 |
| 521 |
PARKINSONISM |
9 |
0.0009 |
| 522 |
DIALYSIS |
13 |
0.0009 |
| 523 |
PANCYTOPENIA |
51 |
0.0009 |
| 524 |
DIFFUSE LARGE B-CELL LYMPHOMA |
7 |
0.0009 |
| 525 |
RHEUMATOID ARTHRITIS |
103 |
0.0009 |
| 526 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
8 |
0.0009 |
| 527 |
PELVIC FRACTURE |
7 |
0.0009 |
| 528 |
FOOT FRACTURE |
17 |
0.0009 |
| 529 |
DERMATITIS ALLERGIC |
11 |
0.0009 |
| 530 |
IMMUNE THROMBOCYTOPENIA |
4 |
0.0009 |
| 531 |
SHOCK |
20 |
0.0009 |
| 532 |
BLOOD URIC ACID INCREASED |
5 |
0.0009 |
| 533 |
SHOCK HAEMORRHAGIC |
7 |
0.0009 |
| 534 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
19 |
0.0009 |
| 535 |
PERIPHERAL SENSORY NEUROPATHY |
5 |
0.0009 |
| 536 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
22 |
0.0009 |
| 537 |
SUDDEN DEATH |
9 |
0.0008 |
| 538 |
NEPHROLITHIASIS |
39 |
0.0008 |
| 539 |
SQUAMOUS CELL CARCINOMA |
8 |
0.0008 |
| 540 |
NEUTROPENIC SEPSIS |
6 |
0.0008 |
| 541 |
CHOLECYSTITIS |
10 |
0.0008 |
| 542 |
ODYNOPHAGIA |
5 |
0.0008 |
| 543 |
PROTHROMBIN TIME PROLONGED |
5 |
0.0008 |
| 544 |
HYPOVOLAEMIC SHOCK |
4 |
0.0008 |
| 545 |
RESPIRATORY DISTRESS |
23 |
0.0008 |
| 546 |
CHOLESTASIS |
16 |
0.0008 |
| 547 |
ENTEROCOCCAL INFECTION |
4 |
0.0008 |
| 548 |
RIB FRACTURE |
17 |
0.0008 |
| 549 |
PERICARDIAL EFFUSION |
19 |
0.0008 |
| 550 |
ORAL DISORDER |
6 |
0.0008 |
| 551 |
GENERALISED OEDEMA |
10 |
0.0008 |
| 552 |
OLIGURIA |
5 |
0.0008 |
| 553 |
HYPERNATRAEMIA |
4 |
0.0008 |
| 554 |
HEPATIC ENZYME ABNORMAL |
4 |
0.0008 |
| 555 |
EOSINOPHILIA |
14 |
0.0008 |
| 556 |
KLEBSIELLA INFECTION |
4 |
0.0008 |
| 557 |
CHOLECYSTECTOMY |
9 |
0.0008 |
| 558 |
LIPASE INCREASED |
6 |
0.0008 |
| 559 |
CYTOMEGALOVIRUS INFECTION |
13 |
0.0008 |
| 560 |
RENAL FAILURE CHRONIC |
6 |
0.0008 |
| 561 |
THERAPY NON-RESPONDER |
35 |
0.0008 |
| 562 |
NERVOUS SYSTEM DISORDER |
24 |
0.0008 |
| 563 |
MALABSORPTION |
4 |
0.0008 |
| 564 |
RENAL CYST |
6 |
0.0008 |
| 565 |
CLOSTRIDIUM DIFFICILE COLITIS |
8 |
0.0008 |
| 566 |
TREMOR |
125 |
0.0008 |
| 567 |
POLYNEUROPATHY |
9 |
0.0008 |
| 568 |
LEUKAEMIA |
7 |
0.0007 |
| 569 |
HYPOKALAEMIA |
34 |
0.0007 |
| 570 |
GASTRIC ULCER |
14 |
0.0007 |
| 571 |
DRUG ERUPTION |
13 |
0.0007 |
| 572 |
DEAFNESS UNILATERAL |
4 |
0.0007 |
| 573 |
GENERALISED TONIC-CLONIC SEIZURE |
12 |
0.0007 |
| 574 |
ANGIOPATHY |
4 |
0.0007 |
| 575 |
BONE DISORDER |
13 |
0.0007 |
| 576 |
CIRCULATORY COLLAPSE |
12 |
0.0007 |
| 577 |
GENERALISED ERYTHEMA |
4 |
0.0007 |
| 578 |
ANOREXIA |
9 |
0.0007 |
| 579 |
ANURIA |
6 |
0.0007 |
| 580 |
MULTI-ORGAN FAILURE |
12 |
0.0007 |
| 581 |
CARDIAC MURMUR |
6 |
0.0007 |
| 582 |
BONE MARROW FAILURE |
14 |
0.0007 |
| 583 |
BRADYKINESIA |
4 |
0.0007 |
| 584 |
CEREBRAL DISORDER |
5 |
0.0007 |
| 585 |
PRESCRIBED OVERDOSE |
13 |
0.0007 |
| 586 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
19 |
0.0007 |
| 587 |
HAEMATEMESIS |
17 |
0.0007 |
| 588 |
MULTIPLE FRACTURES |
11 |
0.0007 |
| 589 |
HYPERLIPIDAEMIA |
8 |
0.0007 |
| 590 |
NEURALGIA |
16 |
0.0007 |
| 591 |
INTENTIONAL PRODUCT USE ISSUE |
57 |
0.0007 |
| 592 |
CARDIOMEGALY |
8 |
0.0006 |
| 593 |
DEAFNESS |
17 |
0.0006 |
| 594 |
LARYNGEAL OEDEMA |
4 |
0.0006 |
| 595 |
APHTHOUS ULCER |
5 |
0.0006 |
| 596 |
DISEASE RECURRENCE |
30 |
0.0006 |
| 597 |
ABSCESS |
10 |
0.0006 |
| 598 |
SENSORY DISTURBANCE |
10 |
0.0006 |
| 599 |
RENAL DISORDER |
29 |
0.0006 |
| 600 |
MOUTH ULCERATION |
13 |
0.0006 |
| 601 |
FEMUR FRACTURE |
19 |
0.0006 |
| 602 |
ENCEPHALOPATHY |
15 |
0.0006 |
| 603 |
MYELOSUPPRESSION |
22 |
0.0006 |
| 604 |
GASTRITIS |
16 |
0.0006 |
| 605 |
IMMUNE SYSTEM DISORDER |
8 |
0.0006 |
| 606 |
SPINAL COMPRESSION FRACTURE |
5 |
0.0006 |
| 607 |
HYPOTONIA |
6 |
0.0006 |
| 608 |
MENINGITIS |
4 |
0.0006 |
| 609 |
ATRIOVENTRICULAR BLOCK COMPLETE |
4 |
0.0006 |
| 610 |
SLUGGISHNESS |
6 |
0.0006 |
| 611 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
4 |
0.0006 |
| 612 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
10 |
0.0006 |
| 613 |
ABNORMAL DREAMS |
16 |
0.0006 |
| 614 |
PANCREATITIS ACUTE |
13 |
0.0006 |
| 615 |
PYELONEPHRITIS |
5 |
0.0006 |
| 616 |
NO THERAPEUTIC RESPONSE |
7 |
0.0006 |
| 617 |
TUMOUR LYSIS SYNDROME |
5 |
0.0006 |
| 618 |
DISSEMINATED INTRAVASCULAR COAGULATION |
8 |
0.0006 |
| 619 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
9 |
0.0006 |
| 620 |
HYPERCALCAEMIA |
7 |
0.0006 |
| 621 |
MUSCLE ATROPHY |
7 |
0.0006 |
| 622 |
OPTIC NEURITIS |
5 |
0.0005 |
| 623 |
PHOTOSENSITIVITY REACTION |
9 |
0.0005 |
| 624 |
BRAIN NEOPLASM |
5 |
0.0005 |
| 625 |
GRAND MAL CONVULSION |
5 |
0.0005 |
| 626 |
DIABETIC KETOACIDOSIS |
13 |
0.0005 |
| 627 |
RASH GENERALISED |
14 |
0.0005 |
| 628 |
VENTRICULAR FIBRILLATION |
6 |
0.0005 |
| 629 |
NODULE |
7 |
0.0005 |
| 630 |
CONDITION AGGRAVATED |
163 |
0.0005 |
| 631 |
RASH PAPULAR |
12 |
0.0005 |
| 632 |
SUICIDAL IDEATION |
49 |
0.0005 |
| 633 |
FLANK PAIN |
5 |
0.0005 |
| 634 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 635 |
MYOCARDITIS |
6 |
0.0005 |
| 636 |
EYELID OEDEMA |
6 |
0.0005 |
| 637 |
POST PROCEDURAL HAEMORRHAGE |
6 |
0.0005 |
| 638 |
STAPHYLOCOCCAL INFECTION |
17 |
0.0005 |
| 639 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 640 |
DRUG TOXICITY |
7 |
0.0005 |
| 641 |
SEPSIS |
57 |
0.0005 |
| 642 |
DECREASED IMMUNE RESPONSIVENESS |
5 |
0.0005 |
| 643 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
9 |
0.0005 |
| 644 |
ATAXIA |
6 |
0.0005 |
| 645 |
MENTAL DISORDER |
22 |
0.0005 |
| 646 |
PNEUMOTHORAX |
8 |
0.0005 |
| 647 |
ULCER |
8 |
0.0005 |
| 648 |
NEOPLASM MALIGNANT |
33 |
0.0005 |
| 649 |
THROMBOCYTOPENIA |
55 |
0.0005 |
| 650 |
SUBDURAL HAEMATOMA |
7 |
0.0005 |
| 651 |
RASH MACULAR |
17 |
0.0005 |
| 652 |
TEMPERATURE INTOLERANCE |
5 |
0.0005 |
| 653 |
AGRANULOCYTOSIS |
9 |
0.0005 |
| 654 |
PHARYNGITIS |
6 |
0.0005 |
| 655 |
NEUROPATHY PERIPHERAL |
46 |
0.0005 |
| 656 |
HYPERTHYROIDISM |
7 |
0.0005 |
| 657 |
ILEUS |
6 |
0.0005 |
| 658 |
HYPOXIA |
17 |
0.0005 |
| 659 |
PYREXIA |
167 |
0.0005 |
| 660 |
VISUAL ACUITY REDUCED |
16 |
0.0005 |
| 661 |
EOSINOPHIL COUNT INCREASED |
4 |
0.0005 |
| 662 |
PLATELET COUNT DECREASED |
51 |
0.0005 |
| 663 |
FOLLICULITIS |
5 |
0.0005 |
| 664 |
HAEMODIALYSIS |
4 |
0.0005 |
| 665 |
HEPATIC ENZYME INCREASED |
32 |
0.0005 |
| 666 |
GLAUCOMA |
9 |
0.0005 |
| 667 |
BONE LOSS |
7 |
0.0005 |
| 668 |
NIGHT SWEATS |
15 |
0.0005 |
| 669 |
HAEMOGLOBIN DECREASED |
47 |
0.0005 |
| 670 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
18 |
0.0005 |
| 671 |
LUNG INFECTION |
7 |
0.0005 |
| 672 |
SKIN DISORDER |
15 |
0.0004 |
| 673 |
BASAL CELL CARCINOMA |
7 |
0.0004 |
| 674 |
GASTROINTESTINAL DISORDER |
40 |
0.0004 |
| 675 |
MYOSITIS |
4 |
0.0004 |
| 676 |
ELECTROCARDIOGRAM QT PROLONGED |
16 |
0.0004 |
| 677 |
BLOOD CALCIUM DECREASED |
5 |
0.0004 |
| 678 |
PALLOR |
12 |
0.0004 |
| 679 |
OBESITY |
7 |
0.0004 |
| 680 |
HYPERGLYCAEMIA |
16 |
0.0004 |
| 681 |
METASTASES TO LUNG |
5 |
0.0004 |
| 682 |
DELIRIUM |
15 |
0.0004 |
| 683 |
ELECTROLYTE IMBALANCE |
5 |
0.0004 |
| 684 |
ERYTHEMA MULTIFORME |
4 |
0.0004 |
| 685 |
SKIN ULCER |
11 |
0.0004 |
| 686 |
HEPATOCELLULAR INJURY |
6 |
0.0004 |
| 687 |
HYPOCALCAEMIA |
8 |
0.0004 |
| 688 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
30 |
0.0004 |
| 689 |
BACTERAEMIA |
5 |
0.0004 |
| 690 |
COAGULOPATHY |
7 |
0.0004 |
| 691 |
WRIST FRACTURE |
5 |
0.0004 |
| 692 |
LOWER LIMB FRACTURE |
8 |
0.0004 |
| 693 |
DEPRESSED MOOD |
22 |
0.0004 |
| 694 |
ALTERED STATE OF CONSCIOUSNESS |
9 |
0.0004 |
| 695 |
TOXICITY TO VARIOUS AGENTS |
70 |
0.0004 |
| 696 |
SEPTIC SHOCK |
18 |
0.0004 |
| 697 |
INTERVERTEBRAL DISC PROTRUSION |
9 |
0.0004 |
| 698 |
SCHIZOPHRENIA |
5 |
0.0004 |
| 699 |
ANGIOEDEMA |
18 |
0.0004 |
| 700 |
KNEE OPERATION |
4 |
0.0004 |
| 701 |
DECREASED APPETITE |
94 |
0.0004 |
| 702 |
NIGHTMARE |
14 |
0.0004 |
| 703 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
8 |
0.0004 |
| 704 |
LEUKOPENIA |
20 |
0.0004 |
| 705 |
POISONING |
5 |
0.0004 |
| 706 |
BLINDNESS |
16 |
0.0004 |
| 707 |
DYSPHAGIA |
37 |
0.0004 |
| 708 |
SYNOVITIS |
7 |
0.0004 |
| 709 |
TOOTH LOSS |
8 |
0.0004 |
| 710 |
PRODUCTIVE COUGH |
18 |
0.0004 |
| 711 |
HYPOTHYROIDISM |
12 |
0.0004 |
| 712 |
HAIR TEXTURE ABNORMAL |
5 |
0.0004 |
| 713 |
POOR QUALITY SLEEP |
8 |
0.0004 |
| 714 |
HYPERKALAEMIA |
13 |
0.0004 |
| 715 |
ABDOMINAL DISTENSION |
38 |
0.0004 |
| 716 |
CORONARY ARTERY DISEASE |
11 |
0.0004 |
| 717 |
DEHYDRATION |
48 |
0.0004 |
| 718 |
HAEMOPTYSIS |
10 |
0.0004 |
| 719 |
HEMIPARESIS |
6 |
0.0004 |
| 720 |
LYMPHOPENIA |
5 |
0.0004 |
| 721 |
NEUTROPENIA |
48 |
0.0004 |
| 722 |
ERECTILE DYSFUNCTION |
9 |
0.0004 |
| 723 |
PARALYSIS |
5 |
0.0003 |
| 724 |
PRODUCT PHYSICAL ISSUE |
7 |
0.0003 |
| 725 |
NEOPLASM PROGRESSION |
12 |
0.0003 |
| 726 |
NEUTROPHIL COUNT DECREASED |
14 |
0.0003 |
| 727 |
RESPIRATORY FAILURE |
25 |
0.0003 |
| 728 |
HIP FRACTURE |
11 |
0.0003 |
| 729 |
WHITE BLOOD CELL COUNT DECREASED |
37 |
0.0003 |
| 730 |
HEADACHE |
211 |
0.0003 |
| 731 |
DRUG ABUSE |
28 |
0.0003 |
| 732 |
THIRST |
6 |
0.0003 |
| 733 |
MYOCLONUS |
4 |
0.0003 |
| 734 |
RASH ERYTHEMATOUS |
16 |
0.0003 |
| 735 |
DRUG INEFFECTIVE |
441 |
0.0003 |
| 736 |
CONFUSIONAL STATE |
54 |
0.0003 |
| 737 |
FEBRILE NEUTROPENIA |
22 |
0.0003 |
| 738 |
NOCTURIA |
4 |
0.0003 |
| 739 |
PLEURAL EFFUSION |
20 |
0.0003 |
| 740 |
IMPAIRED WORK ABILITY |
7 |
0.0003 |
| 741 |
ABDOMINAL PAIN |
76 |
0.0003 |
| 742 |
LUNG DISORDER |
16 |
0.0003 |
| 743 |
MYALGIA |
55 |
0.0003 |
| 744 |
CONJUNCTIVITIS |
6 |
0.0003 |
| 745 |
VOMITING |
152 |
0.0003 |
| 746 |
FAECES DISCOLOURED |
7 |
0.0003 |
| 747 |
DYSARTHRIA |
12 |
0.0003 |
| 748 |
DEPRESSION |
72 |
0.0003 |
| 749 |
WEIGHT DECREASED |
88 |
0.0003 |
| 750 |
COMA |
15 |
0.0003 |
| 751 |
ASTHENIA |
118 |
0.0003 |
| 752 |
OEDEMA |
17 |
0.0003 |
| 753 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
15 |
0.0003 |
| 754 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
4 |
0.0003 |
| 755 |
BLOOD POTASSIUM INCREASED |
5 |
0.0003 |
| 756 |
CEREBRAL HAEMORRHAGE |
11 |
0.0003 |
| 757 |
MUCOSAL INFLAMMATION |
8 |
0.0003 |
| 758 |
ACUTE MYOCARDIAL INFARCTION |
9 |
0.0003 |
| 759 |
COGNITIVE DISORDER |
14 |
0.0003 |
| 760 |
SUICIDE ATTEMPT |
18 |
0.0003 |
| 761 |
SKIN EXFOLIATION |
25 |
0.0003 |
| 762 |
CANDIDA INFECTION |
5 |
0.0003 |
| 763 |
DEATH |
253 |
0.0003 |
| 764 |
GYNAECOMASTIA |
9 |
0.0003 |
| 765 |
BONE PAIN |
17 |
0.0003 |
| 766 |
LOCAL SWELLING |
5 |
0.0003 |
| 767 |
MYOCARDIAL INFARCTION |
50 |
0.0003 |
| 768 |
DEMENTIA |
8 |
0.0003 |
| 769 |
MOVEMENT DISORDER |
9 |
0.0003 |
| 770 |
ANGINA PECTORIS |
8 |
0.0003 |
| 771 |
MYELODYSPLASTIC SYNDROME |
4 |
0.0003 |
| 772 |
HYPOKINESIA |
4 |
0.0003 |
| 773 |
C-REACTIVE PROTEIN INCREASED |
10 |
0.0003 |
| 774 |
CHOLELITHIASIS |
9 |
0.0003 |
| 775 |
HYPOPHAGIA |
7 |
0.0003 |
| 776 |
DYSURIA |
10 |
0.0003 |
| 777 |
VIRAL INFECTION |
9 |
0.0003 |
| 778 |
OESOPHAGEAL CARCINOMA |
8 |
0.0003 |
| 779 |
DIARRHOEA |
171 |
0.0003 |
| 780 |
APHASIA |
8 |
0.0003 |
| 781 |
MUSCULAR WEAKNESS |
30 |
0.0003 |
| 782 |
COLITIS |
10 |
0.0003 |
| 783 |
HAEMATURIA |
9 |
0.0003 |
| 784 |
EPILEPSY |
8 |
0.0003 |
| 785 |
EJECTION FRACTION DECREASED |
4 |
0.0003 |
| 786 |
OEDEMA PERIPHERAL |
31 |
0.0003 |
| 787 |
HAEMATOCHEZIA |
14 |
0.0003 |
| 788 |
THERAPY CESSATION |
13 |
0.0003 |
| 789 |
INFLAMMATION |
13 |
0.0003 |
| 790 |
GASTROINTESTINAL HAEMORRHAGE |
21 |
0.0003 |
| 791 |
PANIC ATTACK |
9 |
0.0002 |
| 792 |
PANCREATITIS |
13 |
0.0002 |
| 793 |
SWELLING FACE |
16 |
0.0002 |
| 794 |
CEREBRAL INFARCTION |
6 |
0.0002 |
| 795 |
CARDIAC ARREST |
20 |
0.0002 |
| 796 |
CEREBROVASCULAR ACCIDENT |
41 |
0.0002 |
| 797 |
GENERAL PHYSICAL HEALTH DETERIORATION |
28 |
0.0002 |
| 798 |
PALPITATIONS |
28 |
0.0002 |
| 799 |
ADVERSE EVENT |
22 |
0.0002 |
| 800 |
FACE OEDEMA |
4 |
0.0002 |
| 801 |
CARDIOVASCULAR DISORDER |
6 |
0.0002 |
| 802 |
SEIZURE |
27 |
0.0002 |
| 803 |
VISION BLURRED |
32 |
0.0002 |
| 804 |
UNDERDOSE |
17 |
0.0002 |
| 805 |
IRRITABILITY |
14 |
0.0002 |
| 806 |
UNRESPONSIVE TO STIMULI |
6 |
0.0002 |
| 807 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 808 |
DISCOMFORT |
14 |
0.0002 |
| 809 |
OFF LABEL USE |
200 |
0.0002 |
| 810 |
METASTASES TO LIVER |
4 |
0.0002 |
| 811 |
MELAENA |
5 |
0.0002 |
| 812 |
DISORIENTATION |
9 |
0.0002 |
| 813 |
HYPOTENSION |
45 |
0.0002 |
| 814 |
GOUT |
4 |
0.0002 |
| 815 |
DISTURBANCE IN ATTENTION |
12 |
0.0002 |
| 816 |
NAUSEA |
176 |
0.0002 |
| 817 |
COUGH |
62 |
0.0002 |
| 818 |
LEUKOCYTOSIS |
4 |
0.0002 |
| 819 |
LOWER RESPIRATORY TRACT INFECTION |
10 |
0.0002 |
| 820 |
LUNG NEOPLASM MALIGNANT |
9 |
0.0002 |
| 821 |
TINNITUS |
10 |
0.0002 |
| 822 |
HYPERTENSION |
46 |
0.0002 |
| 823 |
CARDIO-RESPIRATORY ARREST |
9 |
0.0002 |
| 824 |
ROAD TRAFFIC ACCIDENT |
9 |
0.0002 |
| 825 |
INFECTION |
31 |
0.0002 |
| 826 |
PRODUCT USE IN UNAPPROVED INDICATION |
53 |
0.0002 |
| 827 |
EYE DISORDER |
7 |
0.0002 |
| 828 |
EYE PAIN |
12 |
0.0002 |
| 829 |
RASH |
92 |
0.0002 |
| 830 |
ANXIETY |
60 |
0.0002 |
| 831 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
11 |
0.0002 |
| 832 |
HAEMORRHAGE |
22 |
0.0002 |
| 833 |
URINARY RETENTION |
7 |
0.0002 |
| 834 |
MALAISE |
90 |
0.0002 |
| 835 |
RASH PRURITIC |
11 |
0.0002 |
| 836 |
ABASIA |
5 |
0.0002 |
| 837 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 838 |
WEIGHT INCREASED |
45 |
0.0002 |
| 839 |
HYPOAESTHESIA |
30 |
0.0002 |
| 840 |
HALLUCINATION |
15 |
0.0002 |
| 841 |
SLEEP DISORDER |
14 |
0.0002 |
| 842 |
ABDOMINAL PAIN LOWER |
5 |
0.0002 |
| 843 |
INSOMNIA |
52 |
0.0002 |
| 844 |
ERYTHEMA |
40 |
0.0002 |
| 845 |
ANAPHYLACTIC SHOCK |
5 |
0.0002 |
| 846 |
DYSPEPSIA |
19 |
0.0002 |
| 847 |
HERPES ZOSTER |
11 |
0.0002 |
| 848 |
DERMATITIS |
4 |
0.0002 |
| 849 |
MUSCULOSKELETAL PAIN |
10 |
0.0002 |
| 850 |
MOOD SWINGS |
6 |
0.0002 |
| 851 |
DISEASE PROGRESSION |
22 |
0.0002 |
| 852 |
PNEUMONIA |
60 |
0.0002 |
| 853 |
DEEP VEIN THROMBOSIS |
12 |
0.0002 |
| 854 |
AMNESIA |
12 |
0.0002 |
| 855 |
VERTIGO |
11 |
0.0002 |
| 856 |
MENTAL STATUS CHANGES |
5 |
0.0002 |
| 857 |
PLASMA CELL MYELOMA |
7 |
0.0002 |
| 858 |
HYPONATRAEMIA |
10 |
0.0002 |
| 859 |
FATIGUE |
138 |
0.0002 |
| 860 |
GASTRIC DISORDER |
6 |
0.0002 |
| 861 |
HYPERSOMNIA |
5 |
0.0002 |
| 862 |
PANCREATIC CARCINOMA |
5 |
0.0002 |
| 863 |
BLOOD CHOLESTEROL INCREASED |
8 |
0.0002 |
| 864 |
DYSSTASIA |
5 |
0.0002 |
| 865 |
NO ADVERSE EVENT |
31 |
0.0002 |
| 866 |
CARDIAC DISORDER |
16 |
0.0002 |
| 867 |
SWELLING |
16 |
0.0002 |
| 868 |
SURGERY |
10 |
0.0002 |
| 869 |
POLLAKIURIA |
7 |
0.0002 |
| 870 |
CHEST PAIN |
31 |
0.0002 |
| 871 |
ABDOMINAL DISCOMFORT |
28 |
0.0002 |
| 872 |
PAIN IN EXTREMITY |
49 |
0.0002 |
| 873 |
LACRIMATION INCREASED |
5 |
0.0002 |
| 874 |
INTERSTITIAL LUNG DISEASE |
8 |
0.0002 |
| 875 |
ABDOMINAL PAIN UPPER |
34 |
0.0002 |
| 876 |
AGITATION |
12 |
0.0002 |
| 877 |
GAIT DISTURBANCE |
31 |
0.0002 |
| 878 |
EXTRAPYRAMIDAL DISORDER |
4 |
0.0002 |
| 879 |
SWOLLEN TONGUE |
5 |
0.0002 |
| 880 |
SYNCOPE |
16 |
0.0002 |
| 881 |
UNEVALUABLE EVENT |
12 |
0.0002 |
| 882 |
TACHYCARDIA |
14 |
0.0002 |
| 883 |
LETHARGY |
9 |
0.0002 |
| 884 |
ADVERSE DRUG REACTION |
14 |
0.0002 |
| 885 |
SKIN DISCOLOURATION |
7 |
0.0002 |
| 886 |
ANHEDONIA |
4 |
0.0002 |
| 887 |
GASTROOESOPHAGEAL REFLUX DISEASE |
12 |
0.0001 |
| 888 |
DYSKINESIA |
6 |
0.0001 |
| 889 |
OCULAR HYPERAEMIA |
7 |
0.0001 |
| 890 |
MEMORY IMPAIRMENT |
20 |
0.0001 |
| 891 |
DYSPNOEA |
82 |
0.0001 |
| 892 |
HYPOGLYCAEMIA |
7 |
0.0001 |
| 893 |
SOMNOLENCE |
28 |
0.0001 |
| 894 |
ARTHRALGIA |
57 |
0.0001 |
| 895 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 896 |
PRURITUS |
52 |
0.0001 |
| 897 |
PRODUCT USE ISSUE |
25 |
0.0001 |
| 898 |
INTESTINAL OBSTRUCTION |
5 |
0.0001 |
| 899 |
THERAPEUTIC RESPONSE DECREASED |
8 |
0.0001 |
| 900 |
WHITE BLOOD CELL COUNT INCREASED |
5 |
0.0001 |
| 901 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 902 |
LIMB DISCOMFORT |
4 |
0.0001 |
| 903 |
ARRHYTHMIA |
6 |
0.0001 |
| 904 |
COVID-19 |
22 |
0.0001 |
| 905 |
OVERDOSE |
27 |
0.0001 |
| 906 |
CARDIAC FAILURE CONGESTIVE |
10 |
0.0001 |
| 907 |
HYPERSENSITIVITY |
23 |
0.0001 |
| 908 |
PSORIATIC ARTHROPATHY |
5 |
0.0001 |
| 909 |
CONVULSION |
7 |
0.0001 |
| 910 |
PRODUCT SUBSTITUTION ISSUE |
7 |
0.0001 |
| 911 |
PARAESTHESIA |
19 |
0.0001 |
| 912 |
BACK PAIN |
28 |
0.0001 |
| 913 |
GAIT INABILITY |
4 |
0.0001 |
| 914 |
CHILLS |
14 |
0.0001 |
| 915 |
HYPOACUSIS |
5 |
0.0001 |
| 916 |
STOMATITIS |
7 |
0.0001 |
| 917 |
ECZEMA |
6 |
0.0001 |
| 918 |
SPEECH DISORDER |
6 |
0.0001 |
| 919 |
FEELING HOT |
7 |
0.0001 |
| 920 |
HEART RATE DECREASED |
4 |
0.0001 |
| 921 |
BRADYCARDIA |
6 |
0.0001 |
| 922 |
CARDIAC FAILURE |
9 |
0.0001 |
| 923 |
THROMBOSIS |
9 |
0.0001 |
| 924 |
URINARY TRACT INFECTION |
19 |
0.0001 |
| 925 |
MOBILITY DECREASED |
8 |
0.0001 |
| 926 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0001 |
| 927 |
LOSS OF CONSCIOUSNESS |
14 |
0.0001 |
| 928 |
DIZZINESS |
54 |
0.0001 |
| 929 |
INFLUENZA |
12 |
0.0001 |
| 930 |
EYE SWELLING |
4 |
0.0001 |
| 931 |
NECK PAIN |
6 |
0.0001 |
| 932 |
EPISTAXIS |
8 |
0.0001 |
| 933 |
BLISTER |
6 |
0.0001 |
| 934 |
FLATULENCE |
6 |
0.0001 |
| 935 |
VISUAL IMPAIRMENT |
13 |
0.0001 |
| 936 |
CONTUSION |
10 |
0.0001 |
| 937 |
FALL |
34 |
0.0001 |
| 938 |
ARTHRITIS |
8 |
0.0001 |
| 939 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 940 |
HEART RATE INCREASED |
10 |
0.0001 |
| 941 |
BURNING SENSATION |
7 |
0.0001 |
| 942 |
PAIN |
61 |
0.0001 |
| 943 |
ILL-DEFINED DISORDER |
6 |
0.0001 |
| 944 |
HOSPITALISATION |
15 |
0.0001 |
| 945 |
PERIPHERAL SWELLING |
15 |
0.0001 |
| 946 |
CONSTIPATION |
20 |
0.0001 |
| 947 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 948 |
ARTHROPATHY |
5 |
0.0001 |
| 949 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 950 |
CHEST DISCOMFORT |
9 |
0.0001 |
| 951 |
DRY MOUTH |
7 |
0.0001 |
| 952 |
HYPERHIDROSIS |
11 |
0.0001 |
| 953 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
6 |
0.0001 |
| 954 |
MUSCLE SPASMS |
15 |
0.0001 |
| 955 |
AGGRESSION |
4 |
0.0001 |
| 956 |
MUSCULOSKELETAL STIFFNESS |
7 |
0.0001 |
| 957 |
BLOOD PRESSURE INCREASED |
12 |
0.0001 |
| 958 |
INTENTIONAL OVERDOSE |
5 |
0.0001 |
| 959 |
NERVOUSNESS |
4 |
0.0001 |
| 960 |
ALOPECIA |
15 |
0.0001 |
| 961 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 962 |
BREAST CANCER |
7 |
0.0001 |
| 963 |
PROSTATE CANCER |
6 |
0.0001 |
| 964 |
JOINT SWELLING |
9 |
0.0001 |
| 965 |
COMPLETED SUICIDE |
6 |
0.0001 |
| 966 |
ASTHMA |
8 |
0.0001 |
| 967 |
DRUG WITHDRAWAL SYNDROME |
6 |
0.0001 |
| 968 |
DRUG DOSE OMISSION |
11 |
0.0001 |
| 969 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 970 |
INFLUENZA LIKE ILLNESS |
5 |
0.0001 |
| 971 |
ILLNESS |
6 |
0.0001 |
| 972 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
11 |
0.0001 |
| 973 |
MIGRAINE |
5 |
0.0001 |
| 974 |
FLUSHING |
5 |
0.0000 |
| 975 |
SINUSITIS |
5 |
0.0000 |
| 976 |
URTICARIA |
8 |
0.0000 |
| 977 |
PSORIASIS |
6 |
0.0000 |
| 978 |
PRODUCT QUALITY ISSUE |
6 |
0.0000 |
| 979 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 980 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 981 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 982 |
FEELING ABNORMAL |
9 |
0.0000 |
| 983 |
BLOOD GLUCOSE INCREASED |
7 |
0.0000 |
| 984 |
PRODUCT DOSE OMISSION ISSUE |
10 |
0.0000 |
| 985 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 986 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |